JPRN-UMIN000004855已完成1 期
Phase I pilot study of Wilms' tumor gene WT1 peptide pulsed dendritic cell vaccination combined with gemcitabine for patients with advanced pancreatic cancer - Phase I pilot study of Wilms' tumor gene WT1 peptide pulsed dendritic cell vaccination combined with gemcitabine for patients with advanced pancreatic cancer (DC5)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active other primary malignancies 2)Past history of severe allergy 3)Severe comorbidity (infections, interstitial pneumonia, fibroid lung, cardiovascular disease, renal disease, liver disease, uncontrolled diabetes) 4)Pleural effusion or pericardial fluid requiring treatment 5)Pregnancy, nursing women 6)Male hope to impregnate 7)Carrier of HBV, HTLV-1, HIV and so on 8)Severe psychiatric disease 9)Symptomatic interstitial pneumonia or fibroid lung that be diagnosed by X-ray 10)Past history of autoimmune disease 11)During treatment with immunosuppressive agents 12)Patients whom doctors judged inadequate to the enrollment of this study by other reasons
研究者
相似试验
尚未招募
1 期
Phase I study of Wilms' tumor gene WT1 peptide vaccination combined with gemcitabine for patients with advanced non-small-cell lung canceradvanced or recurrent non-small-cell lung cancerJPRN-UMIN000005226School of Medicine, Keio University10
已完成
1 期
Phase I study of Wilms' tumor gene WT1 peptide pulsed dendritic cell vaccination combined with docetaxel for patients with advanced or recurrent esophageal cancerAdvanced or recurrent esophageal cancerJPRN-UMIN000006704School of Medicine, Keio University10
进行中（未招募）
不适用
Dendritic cell vaccine to treat cancer patientsTherapeutic vaccination with dendritic cells loaded with Wilms' tumor 1 protein in patients with solid tumorsMedDRA version: 14.0Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.0Level: LLTClassification code 10046859Term: VaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-000547-24-BEAntwerp University Hospital
进行中（未招募）
不适用
Therapeutic efficacy of Wilms tumor gene (WT1) mRNA-electroporated autologous dendritic cell vaccination in patients with myeloid malignancies and multiple myeloma:a phase II trial.Therapeutic vaccination with dendritic cells loaded with wilms' tumor 1 protein in patients with myeloid malignancies and multiple myelomaMedDRA version: 12.0Level: LLTClassification code 10046859Term: VaccinationMedDRA version: 12.0Level: LLTClassification code 10024329Term: LeukemiaMedDRA version: 12.0Level: LLTClassification code 10028228Term: Multiple myelomaEUCTR2009-015720-28-BEAntwerp University Hospital
已完成
1 期
Phase I clinical trial of Wilms tumor 1 peptide vaccination for patients with advanced canceradvanced cancerJPRN-UMIN000002771Tokyo Women's Medical University18